Overview
- Regeneron formally announced a Global Capability Centre in Hyderabad and exchanged memorandums with Telangana life‑sciences officials after a delegation visit led by Bari Kowal.
- The company says the centre will be operational in the second half of 2026 and is expected to create hundreds of new roles over the coming years.
- Planned functions include data management, statistical programming, artificial intelligence engineering, clinical trial operations, insights and commercial analytics.
- Telangana officials framed the investment as a boost to Hyderabad’s growing GCC and life‑sciences ecosystem, which they say already hosts roughly 450 Global Capability Centres and projects such as Genome Valley expansion and a proposed Green Pharma City.
- Regeneron positioned the Hyderabad site as a complement to its global operations, but details such as the exact site, investment size and precise staffing timeline have not been disclosed.